1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II study of gemcitabine plus cisplatin chemotherapy in patients with muscleinvasive bladder cancer with bladder preservation for those patients whose tumors harbor deleterious DNA damage response (DDR) gene alterations (Alliance A031701)
    Meeting Abstract

    Iyer, G.; Ballman, K. V.; Atherton, P. J.; Murray, K.; Kwok, Y.; Steen, P. D.; Baghaie, S.; Rosenberg, J. E.; Morris, M. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Assessing effectiveness of first-line carboplatin, pemetrexed, and pembrolizumab in patients with recurrent/metastatic lung adenocarcinoma
    Meeting Abstract

    Ip, A.; Gutierrez, M.; Warren, M. E.; Pfister, D. G.; Brady, O.; Shen, R. L.; Riely, G. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Assessment of telehealth experience among a head and neck oncology population
    Meeting Abstract

    Hung, K. W.; Cracchiolo, J. R.; Kim, S. Y.; Gillespie, E. F.; Pfister, D. G.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance)
    Meeting Abstract

    Iyer, G.; Halabi, S.; Luo, B.; Rosenberg, J. E.; Choi, W.; Al-Ahmadie, H. A.; Mountain, J.; Regazzi, A. M.; Fong, M.; Mouw, K. W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A breast cancer (BC) risk model incorporating Tyrer-Cuzick version 8 (TCv8) and a polygenic risk score (PRS) for diverse ancestries
    Meeting Abstract

    Hughes, E.; Probst, B.; Pederson, H. J.; Simmons, T.; Morris, B.; Domchek, S. M.; Eng, C.; Gary, M.; Gordon, O.; Klemp, J. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067
    Meeting Abstract

    Hodi, F. S.; Chiarion-Sileni, V.; Lewis, K. D.; Grob, J. J.; Rutkowski, P.; Lao, C. D.; Cowey, C. L.; Schadendorf, D.; Wagstaff, J.; Dummer, R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1b study of RGX-202-01, a first-in-class oral inhibitor of the SLC6A8/CKB pathway, in combination with FOLFIRI and bevacizumab (BEV) in second-line advanced colorectal cancer (CRC)
    Meeting Abstract

    Hendifar, A. E.; Rosen, L. S.; Cercek, A.; McRee, A. J.; Mallick, A. B.; Spigel, D. R.; Tavazoie, S. F.; Rowinsky, E. K.; Szarek, M.; Gonsalves, F.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Estimating clear cell renal cell carcinoma transcriptomic signatures using machine learning and histopathology images
    Meeting Abstract

    Hassanpour, S.; Tomita, N.; Kotecha, R.; Lee, C. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1/2 trial to evaluate the safety and antitumor activity of tipifarnib and alpelisib for patients with PIK3CA-mutated/amplified and/or HRAS-overexpressing recurrent/metastatic head and neck squamous cell carcinoma
    Meeting Abstract

    Hanna, G. J.; Perez, C. A.; Ho, A. L.; Gillison, M. L.; Adkins, D.; Dayoub, A.; Saunders, A.; Leoni, M.; Dale, S.; Nie, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A randomized phase III clinical trial of yoga for chemotherapy-induced peripheral neuropathy treatment
    Meeting Abstract

    Han, K.; Dooley, A.; Piulson, L.; Seluzicki, C.; Zhi, W. I.; Bao, T.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save